99% Purity Peptide Powder Bivalirudin CAS: 128270-60-0 for Angina Pectoris

99% Purity Peptide Powder Bivalirudin CAS: 128270-60-0 for Angina pectoris

Quick Details of Bivalirudin:
 



Bivalirudin  Descriptions:

Bivalirudin (Angiomax or Angiox, manufactured by The Medicines Company) is a specific and reversible direct thrombin inhibitor (DTI).
Chemically, it is a synthetic congener of the naturally occurring drug hirudin (found in the saliva of the medicinal leech Hirudo medicinalis).
Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors, such as heparin. Bivalirudin is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin. It inhibits both circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation. Bivalirudin has a quick onset of action and a short half-life. It does not bind to plasma proteins (other than thrombin) or to red blood cells. Therefore, it has a predictable antithrombotic response. There is no risk for Heparin Induced Thrombocytopenia/Heparin Induced Thrombosis-Thrombocytopenia Syndrome (HIT/HITTS). It does not require a binding cofactor such as antithrombin and does not activate platelets. These characteristics make bivalirudin an ideal alternative to heparin.
Bivalirudin clinical studies demonstrated consistent positive outcomes in patients with stable angina, unstable angina (UA), non-ST segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI) undergoing PCI in 7 major randomized trials. Patients receiving bivalirudin had fewer adverse events compared to patients that received heparin.

Bivalirudin  Applications:

Regardless of whether it is thrombin in the blood circulation or thrombin combined with thrombus, bivalirudin can specifically bind to its catalytic site and anion binding site, thereby directly inhibiting the activity of thrombin, and its characteristic is short-lived. ,reversible. Early clinical studies have shown that bivalirudin has a definite anticoagulant effect and has a lower incidence of bleeding events and is safer than traditional heparin anticoagulant therapy. It is mainly used to prevent angioplasty interventional treatment of ischemic complications of unstable angina.
In vitro, this product has both inhibitory effects on both soluble and thrombin-bound thrombin. This effect is not affected by the product of platelet release, and prolongs plasma activated partial thromboplastin time, coagulation in a dose-dependent manner. Enzyme time and prothrombin time. Suitable for percutaneous coronary intervention (PCI) for unstable angina.

Our order process:
Our competitive advantages: 99% Purity Peptide Powder Bivalirudin CAS: 128270-60-0 for Angina pectoris

Quick Details of Bivalirudin:
 



Bivalirudin  Descriptions:

Bivalirudin (Angiomax or Angiox, manufactured by The Medicines Company) is a specific and reversible direct thrombin inhibitor (DTI).
Chemically, it is a synthetic congener of the naturally occurring drug hirudin (found in the saliva of the medicinal leech Hirudo medicinalis).
Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors, such as heparin. Bivalirudin is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin. It inhibits both circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation. Bivalirudin has a quick onset of action and a short half-life. It does not bind to plasma proteins (other than thrombin) or to red blood cells. Therefore, it has a predictable antithrombotic response. There is no risk for Heparin Induced Thrombocytopenia/Heparin Induced Thrombosis-Thrombocytopenia Syndrome (HIT/HITTS). It does not require a binding cofactor such as antithrombin and does not activate platelets. These characteristics make bivalirudin an ideal alternative to heparin.
Bivalirudin clinical studies demonstrated consistent positive outcomes in patients with stable angina, unstable angina (UA), non-ST segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI) undergoing PCI in 7 major randomized trials. Patients receiving bivalirudin had fewer adverse events compared to patients that received heparin.

Bivalirudin  Applications:

Regardless of whether it is thrombin in the blood circulation or thrombin combined with thrombus, bivalirudin can specifically bind to its catalytic site and anion binding site, thereby directly inhibiting the activity of thrombin, and its characteristic is short-lived. ,reversible. Early clinical studies have shown that bivalirudin has a definite anticoagulant effect and has a lower incidence of bleeding events and is safer than traditional heparin anticoagulant therapy. It is mainly used to prevent angioplasty interventional treatment of ischemic complications of unstable angina.
In vitro, this product has both inhibitory effects on both soluble and thrombin-bound thrombin. This effect is not affected by the product of platelet release, and prolongs plasma activated partial thromboplastin time, coagulation in a dose-dependent manner. Enzyme time and prothrombin time. Suitable for percutaneous coronary intervention (PCI) for unstable angina.

Our order process:
Our competitive advantages:

Fat-controling HCA-spirulina tablet is use America material,past international certification. this tablte burning fat effective and no side effect, and it no dependence.

Spirulina is a cyanobacterium that can be consumed by humans and other animals and is made primarily from two species of cyanobacteria, arthrospira platensis and arthrospira maxima, it can control fat to produce and burn fat quickly.

garcinia cambogia: In late 2012, a United States television personality, Dr.Oz, promoted Garcinia cambogia extract as a "magic" weight-loss aid.Dr. Oz's previous endorsements have often led to a substantial increase in consumer interest in the promoted products.

ingredients: spirulina, garcinia cambogia extract,lotus leaf extract, powdered sugar
direction : twice each day, take one with warm water in the morning before breakfast and take one with warm water in the evening before supper.
specification:60pill/bottle

caution crowd :children, heart disease and hypertension

Weight Loss Pills

fat burning capsule,HAC fat burning tablet, weight loss pill, Fat burning pill, slimming pill

GUANGZHOU XIANGGUO BIO-TECHNOLOGY CO., LTD. , http://www.slimmanufacturer.com